Bayer launches Aqua K-Othrine®for mosquito management

Gunjan Chauhan
Gunjan Chauhan
· 3 min read

Rapid urbanization in India has led to a significant rise in vector borne diseases such as Malaria and Dengue. To prevent these diseases, India needs effective and innovative vector control solutions. In line with Bayer’s commitment to safeguard public health, the company has launched Aqua K-Othrine®, India’s first water-based space spray insecticide for management of mosquitoes.

Aqua K-Othrine® is an emulsion in water (EW) formulation. It contains an anti-evaporant to protect the water-based spray droplets from evaporative water loss. This anti-evaporant technology: FFAST (Film Forming Aqueous Spray Technology) enables Aqua K-Othrine® to be diluted in water without losing efficacy. Being water-based, this innovative product eliminates the use of oil-based diluents such as diesel and helps reduce environmental impact. It also reduces the cost of application by upto 80 percent.

Speaking about Bayer’s interventions around vector borne disease management, Dr. Arun Kumar, Head of Environmental Science at Bayer, South Asia, said: “At Bayer, we are committed to using science and innovation to improve people’s lives for the better. Aqua K-Othrine® is a novel product in the vector control segment to help mitigate the spread of mosquito-borne diseases. We will continue to invest significantly in the research for innovative solutions to improve public health and contribute towards Good Health and Well-Being for People.”

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion

The Environmental Science business of Bayer collaborates closely with both private and public players to protect communities and the spaces in which they live, work and play. Speaking about the launch of Bayer’s new innovation in vector control; Sam Easaw, Managing Director, Rentokil PCI, said: “Bayer has a long-standing partnership with Rentokil PCI in India and across the globe. The introduction of Aqua K-Othrine® in India is very timely given the increasing trend of vector borne diseases in various parts of the country.”

Aqua K-Othrine® is pre-qualified by the World Health Organisation (WHO) for use in vector control operations. This WHO assessment provides assurance of effectiveness and safety in use when used according to the label instructions. The product can be used in thermal fogging machines, ultra-low volume (ULV) sprayers and cold fogger machinesagainst flying insect pests. One litre of Aqua K-Othrine is enough to provide coverage of 20 to 40 hectares.

Read Next

Novartis launches Pluvicto®, the Country’s First Regulatory Authority Approved Radioligand Therapy for Advanced Prostate Cancer
News
June 15, 2026

Novartis launches Pluvicto®, the Country’s First Regulatory Authority Approved Radioligand Therapy for Advanced Prostate Cancer

Novartis India announced the launch of Pluvicto(lutetium (177Lu) vipivotide tetraxetan), the country’s first regulatory authority-approved radioligand therapy for eligible patients with Prostate-Specific Membrane Antigen (PSMA)-positive prostate cancer. Designed to precisely target prostate cancer cells while minimizing exposure to healthy tissues, Pluvicto introduces a new treatment approach for metastatic prostate cancer, a disease that continues to […]
Article by: IMT News Desk
India Risks Becoming “Unhealthier Before It Becomes Richer,” CEA V Anantha Nageswaran Warns
News
June 15, 2026

India Risks Becoming “Unhealthier Before It Becomes Richer,” CEA V Anantha Nageswaran Warns

Chief Economic Advisor V Anantha Nageswaran said India’s bigger worry isn’t ageing before it gets rich, but becoming unhealthier before it gets rich, pointing to rising obesity and sedentary lifestyles that threaten the country’s productivity dividend. Responding to the question of whether India will age before it becomes rich due to falling birth rates and […]
Article by: IMT News Desk
HLL Lifecare Launches AMRIT Plus Premium Pharmacy Chain with Advanced Diagnostics Initiative
News
June 15, 2026

HLL Lifecare Launches AMRIT Plus Premium Pharmacy Chain with Advanced Diagnostics Initiative

HLL Lifecare Limited has launched AMRIT Plus, a premium pharmacy chain offering medicines, medical devices and wellness products, along with speciality HINDLABS and home healthcare services, expanding its healthcare access initiatives. The premium pharmacy chain aims to strengthen healthcare access for millions across India by providing quality medical supplies and wellness products at competitive prices. […]
Article by: IMT News Desk
India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk